Bor‐Ru Lin

Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions.

Ann‐Lii Cheng, Chih‐Hung Hsu, Jen‐Kou Lin et al. · PubMed · 2001 · 2.1K citations

Urinary Bladder Cancer, Chemopreventive Agent, Oncology +15

High-dose Dual Therapy Is Superior to Standard First-line or Rescue Therapy for Helicobacter pylori Infection

Jyh‐Chin Yang, Chun‐Jung Lin, Hong-Long Wang et al. · Clinical Gastroenterology and Hepatology · 2014 · 195 citations · Full text

Helicobacter Pylori Infection, High-dose Dual Therapy, Gastroenterology +4

The Induction of Prostaglandin E2 Production, Interleukin-6 Production, Cell Cycle Arrest, and Cytotoxicity in Primary Oral Keratinocytes and KB Cancer Cells by Areca Nut Ingredients Is Differentially Regulated by MEK/ERK Activation

Mei‐Chi Chang, Hui‐Lin Wu, Jang‐Jaer Lee et al. · Journal of Biological Chemistry · 2004 · 127 citations · Full text

Effects of areca nut, inflorescence <i>piper betle</i> extracts and arecoline on cytotoxicity, total and unscheduled DNA synthesis in cultured gingival keratinocytes

Jiiang‐Huei Jeng, Liang‐Jiunn Hahn, Bor‐Ru Lin et al. · Journal of Oral Pathology and Medicine · 1999 · 106 citations

Induction of necrosis and apoptosis to KB cancer cells by sanguinarine is associated with reactive oxygen species production and mitochondrial membrane depolarization

Mei‐Chi Chang, Chiu‐Po Chan, Ying‐Jan Wang et al. · Toxicology and Applied Pharmacology · 2006 · 86 citations

Chemoprevention Strategy, Medicine, Apoptosis +10